2628-3136 Screening compound: (2E)-2-[(4-butoxyphenyl)formamido]-N-(3,4-dichlorophenyl)-3-[4-(dimethylamino)phenyl]prop-2-enamide

2628-3136 Screening compound: (2E)-2-[(4-butoxyphenyl)formamido]-N-(3,4-dichlorophenyl)-3-[4-(dimethylamino)phenyl]prop-2-enamide
2628-3136 Screening compound: (2E)-2-[(4-butoxyphenyl)formamido]-N-(3,4-dichlorophenyl)-3-[4-(dimethylamino)phenyl]prop-2-enamide alternative view

Chemical Structure Depiction of ChemDiv screening compound 2628-3136
(2E)-2-[(4-butoxyphenyl)formamido]-N-(3,4-dichlorophenyl)-3-[4-(dimethylamino)phenyl]prop-2-enamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

2628-3136

Molecular Formula

C28H29Cl2N3O3 (C28 H29 Cl2 N3 O3)

Compound Name

(2E)-2-[(4-butoxyphenyl)formamido]-N-(3,4-dichlorophenyl)-3-[4-(dimethylamino)phenyl]prop-2-enamide

IUPAC name

(2E)-2-[(4-butoxyphenyl)formamido]-N-(34-dichlorophenyl)-3-[4-(dimethylamino)phenyl]prop-2-enamide

SMILES

CCCCOc(cc1)ccc1C(N/C(/C(Nc(cc1)cc(Cl)c1Cl)=O)=C/c(cc1)ccc1N(C)C)=O

InChI

InChI=1S/C28H29Cl2N3O3/c1-4-5-16-36-23-13-8-20(9-14-23)27(34)32-26(17-19-6-11-22(12-7-19)33(2)3)28(35)31-21-10-15-24(29)25(30)18-21/h6-15,17-18H,4-5,16H2,1-3H3,(H,31,35)(H,32,34)

InChI Key

MEJWBXPUQFEORA-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD01842737

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

526.46

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

2.00

Rotatable Bond Count

12.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

7.272

Distribution Coefficient, logD

6.427

Water Solubility, LogSw

-6.58

Polar Surface Area

55.477

Acid Dissociation Constant (pKa)

6.62

Base Dissociation Constant (pKb)

3.75

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

21.40

2628-3136 in Drug Discovery

Included in Screening Libraries

Antimitotic Tubulin Library (17355 compounds)

KRAS-Targeted Library (16000 compounds)

Regenerative Medicine Focused Library (23016 compounds)

?ysteine Targeted Covalent Library (39471 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Musculoskeletal
  • Digestive system
  • Hemic and lymphatic
  • Cardiovascular
  • Skin
  • wounds
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Targets:
  • Kinases
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with 2628-3136 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound 2628-3136?
Check Price and Availability of 2628-3136, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of 2628-3136 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for 2628-3136
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for 2628-3136
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of 2628-3136 available by request